Vaxart (VXRT) to offer common stock

Vaxart, Inc. (Nasdaq: VXRT) today announced that it has commenced an underwritten public offering of its common stock. In addition, Vaxart expects to grant to the underwriter a 30-day option to purchase up to an additional 15% of shares of the common stock sold in the public offering. All of the securities in the offering are to be sold by Vaxart. The offering is subject to market and other customary closing conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Vaxart currently intends to use the net proceeds of the proposed offering to support the clinical and preclinical development of its product candidates, to conduct clinical trials, to manufacture its product candidates, and for general corporate and working capital purposes.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

You May Also Be Interested In

• CrowdStrike (CRWD) PT Adjusted $250 at Cantor Fitzgerald Post Stock Split
• Wrap Technologies closes $12M stock offering at $1.40 per share
• Edesa Biotech launches public offering of common shares